Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
18
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| GOLDMAN SACHS INTERNATIONAL | 10% Owner | 5 | $0 | $0 | 2019-04-01 |
| Roberts Brandi | SVP & Chief Financial Officer | 1 | $0 | $0 | 2017-09-18 |
| GROVES REGINA E | Chief Executive Officer | 12 | $37.1K | $0 | 2017-08-29 |
| KIMES RICHARD M. | Senior VP, Operations | 5 | $9.1K | $0 | 2017-08-17 |
| Breckenridge Ross | Director | 8 | $17.1K | $0 | 2017-07-09 |
| Stockman Robert Bernard | Director | 14 | $376.8K | $0 | 2017-07-09 |
| Thomas Robert Bain | Director | 25 | $527.7K | $0 | 2017-07-09 |
| Huennekens R Scott | Director | 6 | $0 | $0 | 2017-07-09 |
| Schultz Robert K. | President & COO | 14 | $0 | $366.3K | 2017-05-17 |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | 22 | $0 | $188.8K | 2017-03-20 |
| Thompson Katrina | CFO & Secretary | 17 | $24.0K | $0 | 2017-03-20 |
| Brandom Donald K. | VP, Product Development | 46 | $0 | $309.2K | 2016-08-09 |
| Keating Anne | Director | 7 | $114.3K | $0 | 2016-07-21 |
| Nye Gordon E | Director | 8 | $69.3K | $0 | 2016-07-21 |
| Zeltinger Joan K. | VP, Scientific Affairs | 10 | $0 | $0 | 2016-02-26 |
| GOLDMAN SACHS GROUP INC | 10% Owner | 2 | $0 | $0 | 2016-02-12 |
| Taylor Nicholas | 10% Owner | 2 | $0 | $0 | 2015-10-02 |
| SCHIRO JAMES J | Director | 3 | $0 | $0 | 2014-05-12 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| GOLDMAN SACHS INTERNATIONAL | 10% Owner | S Sale | 2019-04-01 | 2019-04-04 | 2,444,695 | — | $0 | 1,930,305 | SEC↗ |
| Roberts Brandi | SVP & Chief Financial Office | A Award deriv | 2017-09-18 | 2017-09-19 | 190,000 | — | $0 | 190,000 | SEC↗ |
| GROVES REGINA E | Chief Executive Officer | P Buy | 2017-08-29 | 2017-08-30 | 387 | $6.37 | $2.5K | 122,109 | SEC↗ |
| GROVES REGINA E | Chief Executive Officer | P Buy | 2017-08-23 | 2017-08-30 | 408 | $6.37 | $2.6K | 121,722 | SEC↗ |
| GROVES REGINA E | Chief Executive Officer | P Buy | 2017-08-21 | 2017-08-21 | 402 | $5.86 | $2.4K | 121,314 | SEC↗ |
| GROVES REGINA E | Chief Executive Officer | P Buy | 2017-08-17 | 2017-08-21 | 303 | $5.57 | $1.7K | 120,912 | SEC↗ |
| KIMES RICHARD M. | Senior VP, Operations | P Buy | 2017-08-17 | 2017-08-21 | 880 | $5.61 | $4.9K | 21,880 | SEC↗ |
| Breckenridge Ross | Director | A Award deriv | 2017-07-09 | 2017-07-11 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Huennekens R Scott | Director | A Award deriv | 2017-07-09 | 2017-07-11 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Stockman Robert Bernard | Director | A Award deriv | 2017-07-09 | 2017-07-11 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Thomas Robert Bain | Director | A Award deriv | 2017-07-09 | 2017-07-11 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Breckenridge Ross | Director | A Award | 2017-07-09 | 2017-07-11 | 6,000 | — | $0 | 30,073 | SEC↗ |
| Huennekens R Scott | Director | A Award | 2017-07-09 | 2017-07-11 | 6,000 | — | $0 | 27,300 | SEC↗ |
| Stockman Robert Bernard | Director | A Award | 2017-07-09 | 2017-07-11 | 6,000 | — | $0 | 288,239 | SEC↗ |
| Thomas Robert Bain | Director | A Award | 2017-07-09 | 2017-07-11 | 6,000 | — | $0 | 27,300 | SEC↗ |
| GOLDMAN SACHS INTERNATIONAL | 10% Owner | P Buy deriv | 2017-06-16 | 2017-06-20 | 166,500 | — | $0 | 166,500 | SEC↗ |
| GOLDMAN SACHS INTERNATIONAL | 10% Owner | P Buy deriv | 2017-06-16 | 2017-06-20 | 0 | — | $0 | 0 | SEC↗ |
| GROVES REGINA E | Chief Executive Officer | A Award deriv | 2017-05-19 | 2017-05-22 | 58,500 | — | $0 | 58,500 | SEC↗ |
| GROVES REGINA E | Chief Executive Officer | A Award | 2017-05-19 | 2017-05-22 | 29,250 | — | $0 | 120,609 | SEC↗ |
| Schultz Robert K. | President & COO | S Sale | 2017-05-17 | 2017-05-19 | 55,000 | $6.66 | $366.3K | 277,000 | SEC↗ |
| GOLDMAN SACHS INTERNATIONAL | 10% Owner | P Buy deriv | 2017-05-05 | 2017-05-09 | 171,000 | — | $0 | 171,000 | SEC↗ |
| GOLDMAN SACHS INTERNATIONAL | 10% Owner | P Buy deriv | 2017-05-05 | 2017-05-09 | 0 | — | $0 | 0 | SEC↗ |
| Anderson Jeffrey A. | SVP, Clinical & Regulatory | A Award deriv | 2017-03-20 | 2017-03-22 | 41,000 | — | $0 | 41,000 | SEC↗ |
| GROVES REGINA E | Chief Executive Officer | A Award deriv | 2017-03-20 | 2017-03-22 | 175,500 | — | $0 | 175,500 | SEC↗ |
| KIMES RICHARD M. | Senior VP, Operations | A Award deriv | 2017-03-20 | 2017-03-22 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Schultz Robert K. | President & COO | A Award deriv | 2017-03-20 | 2017-03-22 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Thompson Katrina | CFO & Secretary | A Award deriv | 2017-03-20 | 2017-03-22 | 52,600 | — | $0 | 52,600 | SEC↗ |
| Anderson Jeffrey A. | SVP, Clinical & Regulatory | A Award | 2017-03-20 | 2017-03-22 | 20,500 | — | $0 | 21,000 | SEC↗ |
| GROVES REGINA E | Chief Executive Officer | A Award | 2017-03-20 | 2017-03-22 | 87,750 | — | $0 | 91,359 | SEC↗ |
| KIMES RICHARD M. | Senior VP, Operations | A Award | 2017-03-20 | 2017-03-22 | 20,500 | — | $0 | 21,000 | SEC↗ |
| Schultz Robert K. | President & COO | A Award | 2017-03-20 | 2017-03-22 | 20,500 | — | $0 | 332,000 | SEC↗ |
| Thompson Katrina | CFO & Secretary | A Award | 2017-03-20 | 2017-03-22 | 26,300 | — | $0 | 161,375 | SEC↗ |
| Anderson Jeffrey A. | SVP, Clinical & Regulatory | A Award deriv | 2016-08-09 | 2016-08-11 | 12,250 | — | $0 | 12,250 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | A Award deriv | 2016-08-09 | 2016-08-11 | 12,250 | — | $0 | 12,250 | SEC↗ |
| Schultz Robert K. | President & COO | A Award deriv | 2016-08-09 | 2016-08-11 | 24,500 | — | $0 | 24,500 | SEC↗ |
| Thompson Katrina | CFO & Secretary | A Award deriv | 2016-08-09 | 2016-08-11 | 16,625 | — | $0 | 16,625 | SEC↗ |
| Keating Anne | Director | A Award deriv | 2016-07-21 | 2016-07-25 | 11,800 | — | $0 | 11,800 | SEC↗ |
| Thomas Robert Bain | Director | A Award deriv | 2016-07-21 | 2016-07-25 | 11,800 | — | $0 | 11,800 | SEC↗ |
| Breckenridge Ross | Director | P Buy | 2016-07-21 | 2016-07-25 | 1,773 | $7.34 | $13.0K | 24,073 | SEC↗ |
| Nye Gordon E | Director | P Buy | 2016-07-21 | 2016-07-25 | 3,354 | $7.34 | $24.6K | 877,785 | SEC↗ |
| Keating Anne | Director | A Award | 2016-07-21 | 2016-07-25 | 6,300 | — | $0 | 21,300 | SEC↗ |
| Thomas Robert Bain | Director | A Award | 2016-07-21 | 2016-07-25 | 6,300 | — | $0 | 21,300 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2016-07-15 | 2016-07-19 | 30,000 | $7.47 | $224.1K | 90,000 | SEC↗ |
| Keating Anne | Director | P Buy | 2016-07-15 | 2016-07-19 | 15,306 | $7.47 | $114.3K | 18,606 | SEC↗ |
| GROVES REGINA E | Chief Executive Officer | P Buy | 2016-07-15 | 2016-07-19 | 2,684 | $7.45 | $20.0K | 3,609 | SEC↗ |
| Stockman Robert Bernard | Director | P Buy | 2016-07-14 | 2016-07-18 | 20,126 | $7.45 | $149.9K | 282,239 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2016-06-28 | 2016-06-30 | 995 | $7.33 | $7.3K | 70,050 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2016-06-24 | 2016-06-27 | 2,074 | $7.29 | $15.1K | 71,045 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2016-06-24 | 2016-06-27 | 1,000 | $7.36 | $7.4K | 73,119 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2016-06-24 | 2016-06-27 | 5 | $7.44 | $40 | 74,119 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2016-06-23 | 2016-06-27 | 463 | $7.80 | $3.6K | 74,124 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2016-06-23 | 2016-06-27 | 463 | $7.80 | $3.6K | 74,587 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2016-06-17 | 2016-06-21 | 2,500 | $7.74 | $19.4K | 77,550 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2016-06-17 | 2016-06-21 | 2,500 | $7.78 | $19.4K | 75,050 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2016-06-17 | 2016-06-21 | 201 | $7.78 | $1.6K | 60,000 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2016-06-17 | 2016-06-21 | 2,299 | $7.80 | $17.9K | 59,799 | SEC↗ |
| Huennekens R Scott | Director | A Award deriv | 2016-05-25 | 2016-05-27 | 11,800 | — | $0 | 11,800 | SEC↗ |
| Nye Gordon E | Director | A Award deriv | 2016-05-25 | 2016-05-27 | 11,800 | — | $0 | 11,800 | SEC↗ |
| Breckenridge Ross | Director | A Award deriv | 2016-05-25 | 2016-05-27 | 11,800 | — | $0 | 11,800 | SEC↗ |
| Stockman Robert Bernard | Director | A Award deriv | 2016-05-25 | 2016-05-27 | 11,800 | — | $0 | 11,800 | SEC↗ |
| Huennekens R Scott | Director | A Award | 2016-05-25 | 2016-05-27 | 6,300 | — | $0 | 21,300 | SEC↗ |
| Nye Gordon E | Director | A Award | 2016-05-25 | 2016-05-27 | 6,300 | — | $0 | 874,431 | SEC↗ |
| Breckenridge Ross | Director | A Award | 2016-05-25 | 2016-05-27 | 6,300 | — | $0 | 22,300 | SEC↗ |
| Stockman Robert Bernard | Director | A Award | 2016-05-25 | 2016-05-27 | 6,300 | — | $0 | 262,113 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2016-03-31 | 2016-04-04 | 2,500 | $8.42 | $21.1K | 57,500 | SEC↗ |
| GROVES REGINA E | Chief Executive Officer | P Buy | 2016-03-30 | 2016-03-31 | 925 | $8.60 | $8.0K | 925 | SEC↗ |
| KIMES RICHARD M. | Senior VP, Operations | P Buy | 2016-03-29 | 2016-03-31 | 500 | $8.39 | $4.2K | 500 | SEC↗ |
| Stockman Robert Bernard | Director | P Buy | 2016-03-29 | 2016-03-31 | 6,500 | $8.49 | $55.2K | 255,813 | SEC↗ |
| Anderson Jeffrey A. | SVP, Clinical & Regulatory | A Award deriv | 2016-02-26 | 2016-03-01 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | A Award deriv | 2016-02-26 | 2016-03-01 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Schultz Robert K. | President & COO | A Award deriv | 2016-02-26 | 2016-03-01 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Thompson Katrina | CFO & Secretary | A Award deriv | 2016-02-26 | 2016-03-01 | 14,250 | — | $0 | 14,250 | SEC↗ |
| Zeltinger Joan K. | VP, Scientific Affairs | A Award deriv | 2016-02-26 | 2016-03-01 | 6,750 | — | $0 | 6,750 | SEC↗ |
| GROVES REGINA E | Chief Executive Officer | A Award deriv | 2016-02-16 | 2016-02-18 | 330,000 | — | $0 | 330,000 | SEC↗ |
| GOLDMAN SACHS GROUP INC | 10% Owner | X Exercise deriv | 2016-02-12 | 2016-02-17 | 4,375,000 | — | $0 | 0 | SEC↗ |
| GOLDMAN SACHS GROUP INC | 10% Owner | X Exercise | 2016-02-12 | 2016-02-17 | 4,375,000 | $2.60 | $11.38M | 4,375,000 | SEC↗ |
| KIMES RICHARD M. | Senior VP, Operations | A Award deriv | 2016-01-27 | 2016-01-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Anderson Jeffrey A. | SVP, Clinical & Regulatory | S Sale | 2015-12-04 | 2015-12-08 | 4,500 | $6.00 | $27.0K | 500 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2015-11-17 | 2015-11-18 | 5,000 | $5.59 | $27.9K | 80,050 | SEC↗ |
| Taylor Nicholas | 10% Owner | M Exercise deriv | 2015-10-02 | 2015-10-05 | 4,375,000 | — | $0 | 0 | SEC↗ |
| Taylor Nicholas | 10% Owner | M Exercise | 2015-10-02 | 2015-10-05 | 4,375,000 | $2.17 | $9.49M | 5,765,230 | SEC↗ |
| GROVES REGINA E | Chief Executive Officer | A Award deriv | 2015-09-24 | 2015-09-28 | 1,670,000 | — | $0 | 1,670,000 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2015-09-21 | 2015-09-22 | 3,663 | $4.37 | $16.0K | 85,050 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2015-09-21 | 2015-09-22 | 2,500 | $4.45 | $11.1K | 88,713 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2015-09-18 | 2015-09-22 | 200 | $4.28 | $856 | 91,213 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2015-09-10 | 2015-09-11 | 1,137 | $4.66 | $5.3K | 91,413 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2015-09-03 | 2015-09-08 | 2,500 | $5.12 | $12.8K | 92,550 | SEC↗ |
| Schultz Robert K. | President & COO | M Exercise deriv | 2015-07-07 | 2015-07-09 | 80,000 | — | $0 | 0 | SEC↗ |
| Schultz Robert K. | President & COO | M Exercise | 2015-07-07 | 2015-07-09 | 80,000 | $1.25 | $100.0K | 311,500 | SEC↗ |
| Zeltinger Joan K. | VP, Scientific Affairs | M Exercise deriv | 2015-07-01 | 2015-07-02 | 10,000 | — | $0 | 0 | SEC↗ |
| Zeltinger Joan K. | VP, Scientific Affairs | M Exercise | 2015-07-01 | 2015-07-02 | 10,000 | $1.25 | $12.5K | 70,000 | SEC↗ |
| Breckenridge Ross | Director | P Buy | 2015-06-04 | 2015-06-05 | 1,000 | $4.09 | $4.1K | 16,000 | SEC↗ |
| Stockman Robert Bernard | Chairman and CEO | P Buy | 2015-06-03 | 2015-06-04 | 6,250 | $4.00 | $25.0K | 249,313 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2015-05-28 | 2015-05-29 | 10,000 | $3.85 | $38.5K | 55,000 | SEC↗ |
| Breckenridge Ross | Director | A Award deriv | 2015-05-27 | 2015-05-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Huennekens R Scott | Director | A Award deriv | 2015-05-27 | 2015-05-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Stockman Robert Bernard | Chairman and CEO | A Award deriv | 2015-05-27 | 2015-05-29 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Breckenridge Ross | Director | A Award | 2015-05-27 | 2015-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Huennekens R Scott | Director | A Award | 2015-05-27 | 2015-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Keating Anne | Director | A Award | 2015-05-27 | 2015-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Nye Gordon E | Director | A Award | 2015-05-27 | 2015-05-29 | 35,000 | — | $0 | 868,131 | SEC↗ |
| Stockman Robert Bernard | Chairman and CEO | A Award | 2015-05-27 | 2015-05-29 | 50,000 | — | $0 | 243,063 | SEC↗ |
| Thomas Robert Bain | Director | A Award | 2015-05-27 | 2015-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | M Exercise deriv | 2015-03-10 | 2015-03-12 | 50,000 | — | $0 | 0 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | M Exercise | 2015-03-10 | 2015-03-12 | 50,000 | $1.25 | $62.5K | 95,050 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2014-12-12 | 2014-12-15 | 3,909 | $3.47 | $13.6K | 47,454 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2014-12-12 | 2014-12-15 | 2,404 | $3.56 | $8.6K | 45,050 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2014-12-11 | 2014-12-15 | 50 | $3.87 | $194 | 51,362 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2014-12-11 | 2014-12-15 | 546 | $3.66 | $2.0K | 51,412 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2014-12-09 | 2014-12-10 | 3,000 | $3.83 | $11.5K | 51,959 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | S Sale | 2014-12-08 | 2014-12-10 | 92 | $3.98 | $364 | 54,959 | SEC↗ |
| Stockman Robert Bernard | Chairman and CEO | P Buy | 2014-11-21 | 2014-11-24 | 25,000 | $3.19 | $79.8K | 193,063 | SEC↗ |
| Stockman Robert Bernard | Chairman and CEO | P Buy | 2014-11-20 | 2014-11-24 | 5,550 | $2.75 | $15.3K | 168,063 | SEC↗ |
| Anderson Jeffrey A. | SVP, Clinical & Regulatory | M Exercise deriv | 2014-10-20 | 2014-10-21 | 5,000 | — | $0 | 15,000 | SEC↗ |
| Anderson Jeffrey A. | SVP, Clinical & Regulatory | M Exercise | 2014-10-20 | 2014-10-21 | 5,000 | $1.00 | $5.0K | 5,000 | SEC↗ |
| Thompson Katrina | CFO & Secretary | M Exercise deriv | 2014-09-18 | 2014-09-22 | 3,575 | — | $0 | 0 | SEC↗ |
| Thompson Katrina | CFO & Secretary | M Exercise deriv | 2014-09-18 | 2014-09-22 | 20,000 | — | $0 | 0 | SEC↗ |
| Thompson Katrina | CFO & Secretary | M Exercise | 2014-09-18 | 2014-09-22 | 3,575 | $1.40 | $5.0K | 135,075 | SEC↗ |
| Thompson Katrina | CFO & Secretary | M Exercise | 2014-09-18 | 2014-09-22 | 20,000 | $1.25 | $25.0K | 131,500 | SEC↗ |
| Zeltinger Joan K. | VP, Scientific Affairs | M Exercise deriv | 2014-09-10 | 2014-09-11 | 20,000 | — | $0 | 0 | SEC↗ |
| Zeltinger Joan K. | VP, Scientific Affairs | M Exercise | 2014-09-10 | 2014-09-11 | 20,000 | $1.00 | $20.0K | 60,000 | SEC↗ |
| Keating Anne | Director | A Award deriv | 2014-05-12 | 2014-05-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Nye Gordon E | Director | A Award deriv | 2014-05-12 | 2014-05-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SCHIRO JAMES J | Director | A Award deriv | 2014-05-12 | 2014-05-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Thomas Robert Bain | Director | A Award deriv | 2014-05-12 | 2014-05-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Anderson Jeffrey A. | SVP, Clinical & Regulatory | A Award deriv | 2014-01-20 | 2014-01-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Brandom Donald K. | SVP, Product Development | A Award deriv | 2014-01-20 | 2014-01-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Schultz Robert K. | President & COO | A Award deriv | 2014-01-20 | 2014-01-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Thompson Katrina | CFO & Secretary | A Award deriv | 2014-01-20 | 2014-01-22 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Zeltinger Joan K. | VP, Scientific Affairs | A Award deriv | 2014-01-20 | 2014-01-22 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Brandom Donald K. | VP, Product Development | M Exercise deriv | 2014-01-09 | 2014-01-13 | 25,000 | — | $0 | 0 | SEC↗ |
| Brandom Donald K. | VP, Product Development | M Exercise deriv | 2014-01-09 | 2014-01-13 | 12,150 | — | $0 | 0 | SEC↗ |
| Schultz Robert K. | President & COO | M Exercise deriv | 2014-01-09 | 2014-01-13 | 85,000 | — | $0 | 0 | SEC↗ |
| Thompson Katrina | CFO & Secretary | M Exercise deriv | 2014-01-09 | 2014-01-13 | 20,000 | — | $0 | 0 | SEC↗ |
| Brandom Donald K. | VP, Product Development | M Exercise | 2014-01-09 | 2014-01-13 | 25,000 | $1.00 | $25.0K | 55,050 | SEC↗ |
| Brandom Donald K. | VP, Product Development | M Exercise | 2014-01-09 | 2014-01-13 | 12,150 | $0.61 | $7.4K | 30,050 | SEC↗ |
| Schultz Robert K. | President & COO | M Exercise | 2014-01-09 | 2014-01-13 | 85,000 | $1.00 | $85.0K | 231,500 | SEC↗ |
| Thompson Katrina | CFO & Secretary | M Exercise | 2014-01-09 | 2014-01-13 | 20,000 | $1.00 | $20.0K | 111,500 | SEC↗ |
| Nye Gordon E | Director | P Buy | 2013-12-13 | 2013-12-17 | 9,600 | $4.65 | $44.6K | 833,131 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2013-12-10 | 2013-12-10 | 2,500 | $4.60 | $11.5K | 45,000 | SEC↗ |
| Brandom Donald K. | VP, Product Development | S Sale | 2013-12-10 | 2013-12-11 | 805 | $4.41 | $3.6K | 22,900 | SEC↗ |
| Brandom Donald K. | VP, Product Development | S Sale | 2013-12-10 | 2013-12-11 | 5,000 | $4.40 | $22.0K | 17,900 | SEC↗ |
| Stockman Robert Bernard | Chairman and CEO | P Buy | 2013-12-10 | 2013-12-11 | 11,500 | $4.49 | $51.6K | 162,513 | SEC↗ |
| Thompson Katrina | CFO & Secretary | P Buy | 2013-12-09 | 2013-12-10 | 4,146 | $4.43 | $18.4K | 91,500 | SEC↗ |
| Brandom Donald K. | VP, Product Development | S Sale | 2013-12-09 | 2013-12-11 | 4,195 | $4.41 | $18.5K | 23,705 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2013-12-06 | 2013-12-10 | 7,500 | $4.03 | $30.2K | 42,500 | SEC↗ |
| Zeltinger Joan K. | VP, Scientific Affairs | M Exercise deriv | 2013-11-12 | 2013-11-14 | 20,000 | — | $0 | 0 | SEC↗ |
| Zeltinger Joan K. | VP, Scientific Affairs | M Exercise | 2013-11-12 | 2013-11-14 | 20,000 | $0.61 | $12.2K | 40,000 | SEC↗ |
| Keating Anne | Director | A Award deriv | 2013-05-29 | 2013-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Nye Gordon E | Director | A Award deriv | 2013-05-29 | 2013-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SCHIRO JAMES J | Director | A Award deriv | 2013-05-29 | 2013-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Stockman Robert Bernard | Chairman and CEO | A Award deriv | 2013-05-29 | 2013-05-31 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Thomas Robert Bain | Director | A Award deriv | 2013-05-29 | 2013-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Stockman Robert Bernard | Chairman and CEO | A Award | 2013-05-29 | 2013-05-31 | 47,500 | — | $0 | 151,013 | SEC↗ |
| Brandom Donald K. | VP, Product Development | M Exercise deriv | 2013-05-13 | 2013-05-15 | 27,850 | — | $0 | 12,150 | SEC↗ |
| Brandom Donald K. | VP, Product Development | M Exercise | 2013-05-13 | 2013-05-15 | 27,850 | $0.61 | $17.0K | 27,900 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | A Award deriv | 2013-01-14 | 2013-01-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Brandom Donald K. | VP, Product Development | A Award deriv | 2013-01-14 | 2013-01-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Schultz Robert K. | President & COO | A Award deriv | 2013-01-14 | 2013-01-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Thompson Katrina | CFO & Secretary | A Award deriv | 2013-01-14 | 2013-01-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Zeltinger Joan K. | VP, Scientific Affairs | A Award deriv | 2013-01-14 | 2013-01-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Schultz Robert K. | President & COO | A Award | 2013-01-14 | 2013-01-16 | 20,000 | — | $0 | 146,500 | SEC↗ |
| Thompson Katrina | CFO & Secretary | A Award | 2013-01-14 | 2013-01-16 | 20,000 | — | $0 | 87,354 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2012-09-13 | 2012-09-14 | 3,000 | $5.39 | $16.2K | 35,000 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | S Sale | 2012-09-13 | 2012-09-14 | 10,000 | $5.43 | $54.3K | 0 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2012-08-28 | 2012-08-28 | 2,000 | $5.60 | $11.2K | 32,000 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2012-08-24 | 2012-08-28 | 3,000 | $5.64 | $16.9K | 30,000 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2012-08-23 | 2012-08-23 | 2,000 | $5.78 | $11.6K | 27,000 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | M Exercise deriv | 2012-08-16 | 2012-08-17 | 10,000 | — | $0 | 20,000 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | M Exercise | 2012-08-16 | 2012-08-17 | 10,000 | $1.00 | $10.0K | 10,000 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | A Award deriv | 2012-07-17 | 2012-07-19 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Brandom Donald K. | VP, Product Development | A Award deriv | 2012-07-17 | 2012-07-19 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Schultz Robert K. | President & COO | A Award deriv | 2012-07-17 | 2012-07-19 | 84,500 | — | $0 | 84,500 | SEC↗ |
| Thompson Katrina | CFO & Secretary | A Award deriv | 2012-07-17 | 2012-07-19 | 84,500 | — | $0 | 84,500 | SEC↗ |
| Zeltinger Joan K. | VP, Scientific Affairs | A Award deriv | 2012-07-17 | 2012-07-19 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Schultz Robert K. | President & COO | A Award | 2012-07-17 | 2012-07-19 | 16,500 | — | $0 | 126,500 | SEC↗ |
| Thompson Katrina | CFO & Secretary | A Award | 2012-07-17 | 2012-07-19 | 16,500 | — | $0 | 67,354 | SEC↗ |
| Thompson Katrina | CFO & Secretary | P Buy | 2012-06-13 | 2012-06-14 | 854 | $6.54 | $5.6K | 50,854 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2012-06-12 | 2012-06-14 | 5,000 | $6.43 | $32.1K | 25,000 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | S Sale | 2012-06-05 | 2012-06-06 | 2,500 | $5.88 | $14.7K | 5,000 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | S Sale | 2012-06-05 | 2012-06-06 | 2,500 | $6.07 | $15.2K | 0 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | S Sale | 2012-06-05 | 2012-06-06 | 2,500 | $5.97 | $14.9K | 2,500 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | S Sale | 2012-06-05 | 2012-06-14 | 2,500 | $6.18 | $15.4K | 0 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | S Sale | 2012-06-05 | 2012-06-14 | 2,500 | $6.16 | $15.4K | 2,500 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | S Sale | 2012-06-05 | 2012-06-14 | 2,500 | $6.16 | $15.4K | 5,000 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2012-06-04 | 2012-06-05 | 5,000 | $6.00 | $30.0K | 20,000 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2012-05-30 | 2012-05-30 | 1,150 | $6.37 | $7.3K | 15,000 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2012-05-30 | 2012-05-30 | 2,000 | $6.56 | $13.1K | 13,850 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | S Sale | 2012-05-30 | 2012-05-31 | 2,500 | $6.56 | $16.4K | 7,500 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2012-05-25 | 2012-05-29 | 5,000 | $6.53 | $32.6K | 11,850 | SEC↗ |
| Brandom Donald K. | VP, Product Development | S Sale | 2012-05-25 | 2012-05-30 | 1,225 | $6.43 | $7.9K | 1,225 | SEC↗ |
| Brandom Donald K. | VP, Product Development | S Sale | 2012-05-25 | 2012-05-30 | 1,175 | $6.53 | $7.7K | 50 | SEC↗ |
| Brandom Donald K. | VP, Product Development | S Sale | 2012-05-25 | 2012-06-14 | 1,175 | $6.54 | $7.7K | 50 | SEC↗ |
| Brandom Donald K. | VP, Product Development | S Sale | 2012-05-25 | 2012-06-14 | 1,225 | $6.54 | $8.0K | 1,225 | SEC↗ |
| Brandom Donald K. | VP, Product Development | S Sale | 2012-05-24 | 2012-05-29 | 50 | $6.54 | $327 | 2,450 | SEC↗ |
| Brandom Donald K. | VP, Product Development | S Sale | 2012-05-24 | 2012-05-29 | 2,500 | $6.44 | $16.1K | 2,500 | SEC↗ |
| Brandom Donald K. | VP, Product Development | S Sale | 2012-05-24 | 2012-05-29 | 2,500 | $6.34 | $15.8K | 5,000 | SEC↗ |
| Brandom Donald K. | VP, Product Development | S Sale | 2012-05-24 | 2012-05-29 | 2,500 | $6.25 | $15.6K | 7,500 | SEC↗ |
| Thomas Robert Bain | Director | P Buy | 2012-05-24 | 2012-05-29 | 1,850 | $6.34 | $11.7K | 6,850 | SEC↗ |
| Keating Anne | Director | A Award deriv | 2012-05-20 | 2012-05-21 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Nye Gordon E | Director | A Award deriv | 2012-05-20 | 2012-05-21 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SCHIRO JAMES J | Director | A Award deriv | 2012-05-20 | 2012-05-21 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Thomas Robert Bain | Director | A Award deriv | 2012-05-20 | 2012-05-21 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | M Exercise deriv | 2012-02-29 | 2012-03-06 | 10,000 | — | $0 | 30,000 | SEC↗ |
| Anderson Jeffrey A. | VP, Clinical & Regulatory | M Exercise | 2012-02-29 | 2012-03-06 | 10,000 | $1.00 | $10.0K | 10,000 | SEC↗ |
| Brandom Donald K. | VP, Product Development | M Exercise deriv | 2012-02-14 | 2012-02-16 | 10,000 | — | $0 | 40,000 | SEC↗ |
| Brandom Donald K. | VP, Product Development | M Exercise | 2012-02-14 | 2012-02-16 | 10,000 | $0.61 | $6.1K | 10,000 | SEC↗ |